Literature DB >> 9725111

Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase.

G N Carmona1, C W Schindler, M Shoaib, R Jufer, E J Cone, S R Goldberg, N H Greig, Q S Yu, D A Gorelick.   

Abstract

A primary enzyme for the metabolism of cocaine is butyrylcholinesterase (BChE). To determine whether the systemic administration of BChE can increase the metabolism of cocaine sufficiently to alter a behavioral effect, rats were tested in a locomotor activity chamber after receiving 17 mg of cocaine per kg intraperitoneally. In rats pretreated intravenously with 5,000 IU of horse serum-derived BChE, the locomotor activity effect was significantly attenuated. BChE pretreatment increased plasma BChE levels approximately 400-fold. When added to rat plasma, this amount of BChE reduced the cocaine half-life from over 5 hr to less than 5 min. BChE altered the cocaine metabolic pattern such that the relatively nontoxic metabolite ecgonine methyl ester was produced, rather than benzoylecgonine. These results suggest that systemic administration of BChE can increase the metabolism of cocaine sufficiently to alter a behavioral effect of cocaine and thus should be investigated as a potential treatment for cocaine abuse.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725111     DOI: 10.1037//1064-1297.6.3.274

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  6 in total

Review 1.  Accelerating cocaine metabolism as an approach to the treatment of cocaine abuse and toxicity.

Authors:  Charles W Schindler; Steven R Goldberg
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

2.  Modification of pharmacokinetic and abuse-related effects of cocaine by human-derived cocaine hydrolase in monkeys.

Authors:  Charles W Schindler; Zuzana Justinova; David Lafleur; Doug Woods; Viktor Roschke; Hussein Hallak; Liora Sklair-Tavron; Godfrey H Redhi; Sevil Yasar; Jack Bergman; Steven R Goldberg
Journal:  Addict Biol       Date:  2012-01-20       Impact factor: 4.280

Review 3.  Acetylcholinesterase inhibition resulting from exposure to inhaled OP can be prevented by pretreatment with BChE in both macaques and minipigs.

Authors:  Yvonne Rosenberg; Ashima Saxena
Journal:  Neuropharmacology       Date:  2020-05-19       Impact factor: 5.250

4.  LARGE SCALE PURIFICATION OF BUTYRYLCHOLINESTERASE FROM HUMAN PLASMA SUITABLE FOR INJECTION INTO MONKEYS; A POTENTIAL NEW THERAPEUTIC FOR PROTECTION AGAINST COCAINE AND NERVE AGENT TOXICITY.

Authors:  Oksana Lockridge; Lawrence M Schopfer; Gail Winger; James H Woods
Journal:  J Med Chem Biol Radiol Def       Date:  2005-07-01

5.  Cocrystallization studies of full-length recombinant butyrylcholinesterase (BChE) with cocaine.

Authors:  Oluwatoyin Ajibola Asojo; Oluyomi Adebola Asojo; Michelle N Ngamelue; Kohei Homma; Oksana Lockridge
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-03-24

Review 6.  Agents in development for the management of cocaine abuse.

Authors:  David A Gorelick; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.